Inhibition of miR-15 protects against cardiac ischemic injury - Test2 - elhamkhani - TriplyDB

Inhibition of miR-15 protects against cardiac ischemic injury

Inhibition of miR-15 protects against cardiac ischemic injury

http://www.wikidata.org/entity/Q35967093

about

Diagnostic, Prognostic, and Therapeutic Value of Circulating miRNAs in Heart Failure Patients Associated with Oxidative Stress Epigenetic associations in relation to cardiovascular prevention and therapeutics Non-coding RNAs in cardiac regeneration Update on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac Disease A neonatal blueprint for cardiac regeneration Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair Epigenetic mechanisms underlying cardiac degeneration and regeneration Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death Epigenetics and miRNA emerge as key regulators of smooth muscle cell phenotype and function Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology MicroRNA-503 and the extended microRNA-16 family in angiogenesis MicroRNAs in stress signaling and human disease Suppression of Induced microRNA-15b Prevents Rapid Loss of Cardiac Function in a Dicer Depleted Model of Cardiac Dysfunction Differential expression of microRNAs in different disease states.Using microRNA as an alternative treatment for hyperlipidemia and cardiovascular disease: cardio-miRs in the pipeline Strategies and Challenges to Myocardial Replacement Therapy Regulatory non-coding RNAs in acute myocardial infarction Developing miRNA therapeutics for cardiac repair in ischemic heart disease Noncoding RNA in age-related cardiovascular diseases Experimental procedures to identify and validate specific mRNA targets of miRNAs The role of microRNAs in regulating myocardial ischemia reperfusion injury Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases Pigmy MicroRNA: surveillance cops in Therapies kingdom The Role of MicroRNAs in Myocardial Infarction: From Molecular Mechanism to Clinical Application miR-24-mediated knockdown of H2AX damages mitochondria and the insulin signaling pathway.MicroRNA-15a inhibition protects against hypoxia/reoxygenation-induced apoptosis of cardiomyocytes by targeting mothers against decapentaplegic homolog 7.Vascular endothelial growth factor signaling in hypoxia and inflammation.Concise review: new frontiers in microRNA-based tissue regeneration.Development of microRNA therapeutics is coming of age.miR-1 exacerbates cardiac ischemia-reperfusion injury in mouse models.miR-133a enhances the protective capacity of cardiac progenitors cells after myocardial infarction.miRNA-30 family inhibition protects against cardiac ischemic injury by regulating cystathionine-γ-lyase expression.MicroRNA and mRNA signatures in ischemia reperfusion injury in heart transplantation.Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.Effects of statin on circulating microRNAome and predicted function regulatory network in patients with unstable angina.MicroRNAs and Cardiac Regeneration TLR4 Expression Is Associated with Left Ventricular Dysfunction in Patients Undergoing Coronary Artery Bypass Surgery Chronic Losartan Treatment Up-Regulates AT1R and Increases the Heart Vulnerability to Acute Onset of Ischemia and Reperfusion Injury in Male Rats.Casz1 is required for cardiomyocyte G1-to-S phase progression during mammalian cardiac development Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.

P2860

Q26744498-D105FF8C-BC39-4216-89D0-577B39973FAC Q26771428-DA64230F-87A1-4F82-9DCC-40B895D2FE69 Q26783717-F69E1B02-16D6-427E-B169-66B70BCDDD2B Q26801907-F83578C9-3B98-4161-BB27-D185BDC39E88 Q26827943-7A3077C8-A890-4D94-A0C2-8F0D7B316B31 Q26852506-2EBF0A4E-4DBE-4EE4-8C87-0BCD44EB09AC Q26853220-A89ACBFB-A3DD-4F89-80B7-3F7F7BD26BC1 Q26995349-2FECCC3F-6EDC-4E57-92FE-75C43B6CB3A8 Q27006515-44A2C07C-5D96-4612-A1FC-18BEEC523CEF Q27024879-F3523FDB-CB79-47BE-B369-168029533472 Q27026732-B8F6F882-C4B9-4F77-BBB6-2CD5DCF9C62E Q27027517-28FE5DF6-E2A8-4222-BED5-584D3BA573EF Q27313741-CE7F7CA4-1D58-46F9-884C-B5039D8894DF Q27693279-AB80AD01-3243-48D3-BC12-E9ECB56FA40A Q27694686-DB34DE54-A049-4B03-A3BF-603B73E2CEF0 Q28068007-86256285-17E1-4599-9BEE-B20A90457EA7 Q28077279-4083C187-8651-4CD5-944D-5DC4DA0ABB49 Q28077986-6D1EFDDC-66C1-409B-8C26-E1C52FC42235 Q28081466-301D7CD0-5C8E-4EAA-93F9-15E57A9C1DB3 Q28087216-37CCF014-6265-455B-8F72-64440B0D9AA2 Q28088604-96CEA4F1-DA1E-4183-A474-239821B8AFBA Q28583018-8B3816CD-9FD5-496F-A982-A59F4CD4E5D6 Q28818470-C124CE40-3A98-41C9-BA22-4A9C13942E46 Q33624461-B78C83A7-8C52-46E3-AD6B-4355315C5D23 Q33646200-78E1D764-92F3-4E67-9794-8802A95F2623 Q33702159-724630B6-623F-48E5-8148-D11052B8AC0C Q33721685-FEE0BDE6-3297-4EF1-91B5-062AA6238B31 Q33975631-CBF7364D-CFCE-4732-A033-0C1D2FD6AD1B Q33991443-56086A0F-3E09-4B32-912C-5E6B88AE4098 Q34505459-E58F67E8-8F2C-4E29-8635-0B0A5CD8EA14 Q34684493-11BDB91A-0B71-4C2C-AC23-CBE17AC92D46 Q34811514-F4224EFF-7759-490C-BB40-5F36451F594B Q35053280-0EEFA67C-0F61-4970-AF0C-5263248A555B Q35108974-B1D2A841-BCF5-4400-A794-DC89F121BD1D Q35191515-AD8C2F0F-9E28-4142-B5A5-E5D5848DBF16 Q35597374-25569F0B-26C2-48A7-9AF2-05874CEF19CB Q35648432-B80D7F11-5C87-4C25-BCE3-16D3B764CE44 Q35689575-453E9FA0-AD5B-4D0B-892D-7D622A1D4D83 Q35700881-6E5F9161-D5DE-4C1E-8790-7AB32A7282D6 Q35735278-4032E9ED-AA2A-4370-AEB5-2492FF093BCB

P2860

Inhibition of miR-15 protects against cardiac ischemic injury

http://www.wikidata.org/entity/Q35967093

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Inhibition of miR-15 protects against cardiac ischemic injury

@ast

Inhibition of miR-15 protects against cardiac ischemic injury

@en

type

label

Inhibition of miR-15 protects against cardiac ischemic injury

@ast

Inhibition of miR-15 protects against cardiac ischemic injury

@en

prefLabel

Inhibition of miR-15 protects against cardiac ischemic injury

@ast

Inhibition of miR-15 protects against cardiac ischemic injury

@en

P1433

Q35967093-35B3AA8C-F823-4AA6-A2D5-7F910D3A5F53

P1476

Q35967093-F90FC3FD-8182-4500-8FE4-E8DD27635823

P2093

Q35967093-07ADB665-E330-45BA-91D8-D6F3D1C3FD00

Q35967093-10E0AF8C-2265-4D48-B219-724CE85BF0F6

Q35967093-269C6388-CF25-4EB2-B62D-5E6789938716

Q35967093-2CCB7B9D-E270-49A5-BCC3-590FD6FAA89C

Q35967093-3DE8325D-F7E6-4D48-8C50-DDA236DAEAEE

Q35967093-5635AB8E-C51E-4F3F-AC73-8BD3E31100FC

Q35967093-56492922-CD28-4A5C-9287-EEDB4FEFD066

Q35967093-60F7666F-F8B8-4B12-BD61-9BB5B417702A

Q35967093-7A7DCF2C-7FD6-4F9D-B10E-2126DD4FBBAA

Q35967093-7A8FD3CB-AF7A-47DD-AE3A-5DD206130220

P2860

Q35967093-026F89EA-75BF-4402-844C-0773E8381ED3

Q35967093-11591F52-6342-428B-B171-5379A05549CB

Q35967093-28CC6C36-1140-424D-A82B-DCA4704A5645

Q35967093-29A8666C-1552-4827-8160-EAAEE4AAF6EB

Q35967093-35CF15EE-EF09-447F-AC75-4CFC266BDA96

Q35967093-5D8962C9-5893-480F-BD7D-359EB718303C

Q35967093-662B4B54-2713-42A2-A0D0-1F9E357588B1

Q35967093-6B78B3A6-2352-4F57-BCF6-D5305A4050C1

Q35967093-6CF72C4C-FCB6-4494-9AFF-BB7E01AD6217

Q35967093-70B8EABE-C46F-4E2C-83C7-39615CA61D0B

P304

Q35967093-7C54A664-DC09-47E7-9E2C-53CA47C41897

P31

Q35967093-3AC529C4-E549-4913-8119-176E47041901

P356

Q35967093-F1073513-E95F-4BAE-BFAC-707CF5B79467

P433

Q35967093-EB3C5DCC-34F5-4681-A8B9-697B7B5434E7

P478

Q35967093-C9037F6C-9159-415D-A498-46FA29D7A46E

P577

Q35967093-B5326C0F-44A3-4CBC-8F1B-E174A4C2A0CF

P698

Q35967093-D2A162DE-67FC-421A-950E-87D1194F2398

P932

Q35967093-C8651DBB-4E38-4DFF-950D-A7059C47A294

P356

CIRCRESAHA.111.244442

P1433

Circulation Research

P1476

Inhibition of miR-15 protects against cardiac ischemic injury

@en

P2093

Anita G Seto

http://www.w3.org/2001/XMLSchema#string

Brent A Dickinson

http://www.w3.org/2001/XMLSchema#string

Christianna Stack

http://www.w3.org/2001/XMLSchema#string

Christina M Dalby

http://www.w3.org/2001/XMLSchema#string

Eric N Olson

http://www.w3.org/2001/XMLSchema#string

Eva van Rooij

http://www.w3.org/2001/XMLSchema#string

Hillary M Semus

http://www.w3.org/2001/XMLSchema#string

Joshua M Hare

http://www.w3.org/2001/XMLSchema#string

Joshua M Lynch

http://www.w3.org/2001/XMLSchema#string

Kathryn Robinson

http://www.w3.org/2001/XMLSchema#string

P2860

miR-15 and miR-16 induce apoptosis by targeting BCL2

Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice

Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver

Silencing of microRNAs in vivo with 'antagomirs'

MicroRNAs: genomics, biogenesis, mechanism, and function

miR-15a and miR-16-1 in cancer: discovery, function and future perspectives

MicroRNAs and ischemic heart disease: towards a better comprehension of pathogenesis, new diagnostic tools and new therapeutic targets

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

Serum and glucocorticoid-responsive kinase-1 regulates cardiomyocyte survival and hypertrophic response

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

P304

71-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCRESAHA.111.244442

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22052914

http://www.w3.org/2001/XMLSchema#string

P932

3354618

http://www.w3.org/2001/XMLSchema#string